Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 4
Submit an article Journal homepage
32
Views
0
CrossRef citations to date
0
Altmetric
Theme: Stroke - Editorial

Should statins be included in standard care following ischemic stroke in young people?

Jukka Putaala Department of Neurology, Helsinki University Central Hospital and Division of Neurosciences, Helsinki University, Helsinki, Finland and Department of Neurology, Helsinki University Central Hospital, Haartmaninkatu 4, FIN-00290, Helsinki, Finland. [email protected]
&
Turgut Tatlisumak Department of Neurology, Helsinki University Central Hospital and Division of Neurosciences, Helsinki University, Helsinki, Finland and Department of Neurology, Helsinki University Central Hospital, Haartmaninkatu 4, FIN-00290, Helsinki, Finland
Pages 403-405 | Published online: 10 Jan 2014

References

  • Amarenco P, Bogousslavsky J, Callahan A III et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med.355(6), 549–559 (2006).
  • Chaturvedi S, Zivin J, Breazna A et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology72(8), 688–694 (2009).
  • Amarenco P, Benavente O, Goldstein LB et al. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke40(4), 1405–1409 (2009).
  • Sillesen H, Amarenco P, Hennerici MG et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke39(12), 3297–3302 (2008).
  • Amarenco P, Goldstein LB, Callahan A III et al. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis204(2), 515–520 (2009).
  • Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol.9(11), 1085–1096 (2010).
  • Nedeltchev K, der Maur TA, Georgiadis D et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J. Neurol. Neurosurg. Psychiatry76(2), 191–195 (2005).
  • Putaala J, Metso AJ, Metso TM et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke40(4), 1195–1203 (2009).
  • George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995–2008. Ann. Neurol.70(5), 713–721 (2011).
  • Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke24(1), 35–41 (1993).
  • Raitakari OT, Juonala M, Kahonen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA290(17), 2277–2283 (2003).
  • Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann. Neurol.54(2), 227–234 (2003).
  • Putaala J, Haapaniemi E, Kaste M, Tatlisumak T. Statins after ischemic stroke of undetermined etiology in young adults. Neurology77(5), 426–430 (2011).
  • Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol.3(5), 271–278 (2004).
  • Kennedy J, Hill MD, Ryckborst KJ et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol.6(11), 961–969 (2007).
  • Ni Chroinin D, Callaly EL, Duggan J et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke42(4), 1021–1029 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.